These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12737421)

  • 1. Review of drug-related legislation in the Republic of Fiji Islands.
    Bailey MC
    Pac Health Dialog; 2002 Mar; 9(1):68-75. PubMed ID: 12737421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater access to generic drugs. New FDA initiatives to improve drug reviews and reduce legal loopholes.
    Meadows M
    FDA Consum; 2003; 37(5):12-7. PubMed ID: 14666900
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand.
    Ghosh D; Skinner M; Ferguson LR
    Toxicology; 2006 Apr; 221(1):88-94. PubMed ID: 16481089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the Kennedy drug bill could affect the physician's practice. A critique of the Drug Utilization improvement Act of 1974 (S 3441).
    Brennan BJ
    J Leg Med (N Y); 1974; 2(4):25-8. PubMed ID: 4546431
    [No Abstract]   [Full Text] [Related]  

  • 8. Fijian participation in health research: analysis of Medline publications 1965-2002.
    Cuboni HD; Finau SA; Wainiqolo I; Cuboni G
    Pac Health Dialog; 2004 Mar; 11(1):59-78. PubMed ID: 18181444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic substitution of pharmaceuticals.
    Bollen M
    Aust Fam Physician; 1994 Dec; 23(12):2254-5. PubMed ID: 7848139
    [No Abstract]   [Full Text] [Related]  

  • 12. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["God's pharmacy"].
    Kimbel KH
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):117-8. PubMed ID: 6245351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BRITISH PHARMACY. DRUG LEGISLATION AND NATIONAL HEALTH SERVICE].
    JOLDAL B
    Sven Farm Tidskr; 1964 Oct; 68():796-804. PubMed ID: 14226929
    [No Abstract]   [Full Text] [Related]  

  • 16. The end of the beginning?
    Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guiding principles for the interpretation of reimbursement categories applicable in definite indications of psychiatric drugs].
    Bánki CM
    Psychiatr Hung; 2007; 22(1):82-8. PubMed ID: 17642122
    [No Abstract]   [Full Text] [Related]  

  • 18. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic medicines--how confident should we be?
    Weekes L; Ramzan I
    Pac Health Dialog; 2010 Sep; 16(2):109-11. PubMed ID: 21714347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.